Work

Evaluation of the therapeutic effects of brivanib, a novel inhibitor of VEGF receptor tyrosine kinase, on hepatocellular cellular carcinoma xenografts using 1H HR-MAS spectroscopy

FWCI:
Cites:
Cited by:
Related to: 20